Simonetta Viviani
Overview
Explore the profile of Simonetta Viviani including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
107
Citations
2270
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Marchi S, Guarducci G, Marotta M, Peccetti B, Viviani S, Messina G, et al.
J Prev Med Hyg
. 2025 Jan;
65(3):E312-E322.
PMID: 39758773
The emergence of SARS-CoV-2 has underscored the critical need to enhance the ONE HEALTH approach which recognizes the interconnectedness of human, animal, and environmental health. In this review we report...
2.
3.
Sow S, Tapia M, Haidara F, Diallo F, Han X, Chen J, et al.
Int J Infect Dis
. 2024 Sep;
148:107237.
PMID: 39270925
Objectives: ZR-202-CoV and ZR-202a-CoV are novel recombinant vaccines containing 25 µg of the prototype (Wuhan strain) or B.1.351 strain (Beta variant) SARS-CoV-2 S-protein expressed in CHO cells, respectively, adjuvanted with...
4.
Broccoli A, Margiotta-Casaluci G, Pagani C, Steffanoni S, Viviani S, Zinzani P, et al.
Leuk Lymphoma
. 2024 Sep;
65(14):2207-2210.
PMID: 39225366
No abstract available.
5.
Marchi S, Piccini G, Cantaloni P, Guerrini N, Zannella R, Coluccio R, et al.
J Med Virol
. 2024 Jun;
96(6):e29728.
PMID: 38860589
Since May 2022, several countries outside of Africa experienced multiple clusters of monkeypox virus (MPXV)-associated disease. In the present study, anti-MPXV and anti-vaccinia virus (VACV) neutralizing antibody responses were evaluated...
6.
Viviani S, Vanazzi A, Frassoni S, Rusconi C, Rossi A, Romano A, et al.
Leuk Lymphoma
. 2024 Jan;
65(4):460-471.
PMID: 38164812
Data on the efficacy of high-dose chemotherapy and autologous stem cell transplantation (ASCT) for classical Hodgkin lymphoma (cHL) patients who failed a PET-driven first-line therapy are limited.We retrospectively evaluated 220...
7.
Minoia C, Viviani S, Silvestris E, Palini S, Parissone F, De Palma G, et al.
Front Oncol
. 2023 Sep;
13:1252433.
PMID: 37766870
Introduction: Fertility preservation (FP) and monitoring has considerable relevance in the multidisciplinary approach to cancer patients. In these consensus-based practical recommendations, the scientific societies Fondazione Italiana Linfomi (FIL) and Società...
8.
Sow S, Tapia M, Haidara F, Diallo F, Traore Y, Traore A, et al.
Hum Vaccin Immunother
. 2023 Jul;
19(2):2230829.
PMID: 37401618
Affordable, polyvalent meningococcal vaccines are needed for use in emergency reactive immunization campaigns. A phase IV randomized, observer-blind, controlled study compared the safety and immunogenicity of a quadrivalent meningococcal polysaccharide...
9.
Gotti M, Sciarra R, Pulsoni A, Merli F, Luminari S, Zerbi C, et al.
Hemasphere
. 2023 Apr;
7(4):e837.
PMID: 37034003
Nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL) is a rare entity whose neoplastic cells retain a B-cell phenotype with expression of CD20. Radiotherapy is recommended for favorable stage IA disease while for...
10.
Marchi S, Coppola C, Piu P, Benincasa L, Dapporto F, Manenti A, et al.
Z Gesundh Wiss
. 2023 Feb;
:1-6.
PMID: 36776202
Aim: The present study aimed at assessing the prevalence of antibodies against SARS-CoV-2 in the general population in the province of Bari (Apulia region, Southern Italy) during the year 2020....